ArticleJournal of gastrointestinal cancer2024

Efficacy and Safety of Salvage-line Nivolumab Monotherapy for Advanced Esophageal Squamous Cell Carcinoma: Comparison of 240 mg Versus 480 mg Doses.

Yuko Murashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.